FDA Application
-
NDC Search Results on Active Ingredient: Diclofenac
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
DICLOFENAC POTASSIUM | 12634-827-81 | APOTHECA, INC | ANDA075229 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 12634-827-84 | APOTHECA, INC | ANDA075229 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 12634-827-85 | APOTHECA, INC | ANDA075229 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 12634-827-91 | APOTHECA, INC | ANDA075229 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 13107-269-47 | Aurolife Pharma LLC | ANDA213040 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 13913-008-11 | Assertio Therapeutics, Inc. | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 13913-008-12 | Assertio Therapeutics, Inc. | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 13913-008-94 | Assertio Therapeutics, Inc. | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 13913-011-01 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 13913-011-19 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 13913-012-01 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 13913-012-02 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 13913-012-03 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC POTASSIUM | 15370-180-10 | CARWIN PHARMACEUTICAL ASSOCIATES, LLC | ANDA076561 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 15370-180-60 | CARWIN PHARMACEUTICAL ASSOCIATES, LLC | ANDA076561 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 15370-185-30 | CARWIN PHARMACEUTICAL ASSOCIATES, LLC | ANDA076561 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-101-25 | Rising Pharmaceuticals, Inc. | ANDA078553 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-101-50 | Rising Pharmaceuticals, Inc. | ANDA078553 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-201-06 | Rising Pharma Holdings, Inc. | ANDA077863 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-201-10 | Rising Pharma Holdings, Inc. | ANDA077863 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-201-11 | Rising Pharma Holdings, Inc. | ANDA077863 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-201-50 | Rising Pharma Holdings, Inc. | ANDA077863 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-202-06 | Rising Pharma Holdings, Inc. | ANDA090066 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-202-10 | Rising Pharma Holdings, Inc. | ANDA090066 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-202-11 | Rising Pharma Holdings, Inc. | ANDA090066 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 16571-203-10 | Rising Pharma Holdings, Inc. | ANDA090066 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 17856-0833-1 | ATLANTIC BIOLOGICALS CORP. | ANDA208077 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 21130-028-10 | Safeway, Inc. | ANDA208077 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 21130-028-50 | Safeway, Inc. | ANDA208077 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 21130-313-01 | Safeway | ANDA211253 | HUMAN OTC DRUG | ANDA |
-